Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Pulmonary/Rheumatology Division Sees Management Shakeup

Apr 24 2018

• By Ramsey Baghdadi

FDA entrance sign 2016

Related Content

FDA panel backs Breo adult asthma use; rejects adolescents

Mar 20 2015

Lilly's Baricitinib Wins US FDA Panel Thumbs Up For One Of Two Doses

Apr 24 2018

FDA Endocrinology Division To Be Led By Thanh Hai On Interim Basis; Guettier Leaving For Private Sector

Dec 08 2017

FDA panel backs InterMune's pulmonary fibrosis drug Esbriet despite reservations

Mar 10 2010

Related Companies

AstraZeneca PLC

Roche Holding AG

Roche Holding AG

Pfizer Inc.

Sanofi

Eli Lilly and Company

Genentech, Inc.

Additional Topics

United States FDA Regulation Inflammation Respiratory BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window